These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 340402)

  • 1. Mechanisms underlying the differential sensitivity of proliferating and resting cells to external factors.
    Epifanova OI
    Int Rev Cytol Suppl; 1977; (5):303-35. PubMed ID: 340402
    [No Abstract]   [Full Text] [Related]  

  • 2. Plateau-phase cultures of mammalian cells: an in vitro model for human cancer.
    Hahn GM; Little JB
    Curr Top Radiat Res Q; 1972 Jul; 8(1):39-43. PubMed ID: 4678087
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metabolism of proliferating and resting cells].
    Epifanova OI
    Tsitologiia; 1979 Dec; 21(12):1379-96. PubMed ID: 390793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cell cycle.
    Baserga R
    N Engl J Med; 1981 Feb; 304(8):453-9. PubMed ID: 6161307
    [No Abstract]   [Full Text] [Related]  

  • 5. Action of dihydroxyanthraquinone on cell cycle progression and survival of a variety of cultured mammalian cells.
    Traganos F; Evenson DP; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1980 Mar; 40(3):671-81. PubMed ID: 6162553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sharp differences in the stability of DNA--protein interactions of resting and proliferating cells].
    S'iakste NI; Zaboĭkin MM; Baryshnikov AIu; Likhtenshteĭn AV; Shapot VS
    Dokl Akad Nauk SSSR; 1981; 257(1):237-41. PubMed ID: 7238295
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in membrane transport function in G0 and G1 cells.
    Costlow M; Baserga R
    J Cell Physiol; 1973 Dec; 82(3):411-9. PubMed ID: 4359534
    [No Abstract]   [Full Text] [Related]  

  • 8. [The action of antimitotics and the cell cycle].
    Deysson G
    Bull Assoc Anat (Nancy); 1979 Mar; 63(180):83-107. PubMed ID: 393327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in membrane function and chromatin template activity in diploid and transformed cells in culture.
    Baserga R; Costlow M; Rovera G
    Fed Proc; 1973 Nov; 32(11):2115-8. PubMed ID: 4356496
    [No Abstract]   [Full Text] [Related]  

  • 10. Go and Go,2 cells as identified by their chromatin pattern in dormant and proliferating meristems.
    Sans J; de la Torre C
    Eur J Cell Biol; 1979 Aug; 19(3):294-8. PubMed ID: 488128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of three nitrosourea derivatives on mammalian cell cycle progression.
    Tobey RA; Crissman HA
    Cancer Res; 1975 Feb; 35(2):460-70. PubMed ID: 1167349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-dependent changes in drug sensitivity expressed by mammalian cells after exposure to trypsin.
    Barranco SC; Bolton WE; Novak JK
    J Natl Cancer Inst; 1980 Apr; 64(4):913-6. PubMed ID: 6929002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific and non-specific inhibition of normal and tumor growth.
    Fremuth F
    Acta Univ Carol Med Monogr; 1984; 109():1-128. PubMed ID: 6537724
    [No Abstract]   [Full Text] [Related]  

  • 14. Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review).
    Van den Neste E; Cardoen S; Offner F; Bontemps F
    Int J Oncol; 2005 Oct; 27(4):1113-24. PubMed ID: 16142330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replicative activity of isolated chromatin from proliferating and quiescent early passage and aging cultured mouse cells.
    Weisman-Shomer P; Kaftory A; Fry M
    J Cell Physiol; 1979 Nov; 101(2):219-27. PubMed ID: 511952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of cell cycle-related changes in postmitotic and quiescent AF8 cells as measured by cytofluorometry after acridine orange staining.
    Ashihara T; Traganos F; Baserga R; Darzynkiewicz Z
    Cancer Res; 1978 Aug; 38(8):2514-8. PubMed ID: 667846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
    Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
    Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 9,10-anthracenedione, 1,4-bis[[2-[(2-hydroxyethyl)amino]-ethyl]amino]-, diacetate on cell morphology and nucleic acids of friend leukemia cells.
    Evenson DP; Traganos F; Darzynkiewicz Z; Staiano-Coico L; Melamed MR
    J Natl Cancer Inst; 1980 Apr; 64(4):857-66. PubMed ID: 6928997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferation-dependent cytotoxicity of anticancer agents: a review.
    Valeriote F; van Putten L
    Cancer Res; 1975 Oct; 35(10):2619-30. PubMed ID: 1098765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An electron microscopic study of mitosis in mouse duodenal crypt cells confirms that the prophasic condensation of chromatin begins during the DNA-synthesizing (S) stage of the cycle.
    el-Alfy M; Leblond CP
    Am J Anat; 1989 Sep; 186(1):69-84. PubMed ID: 2782289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.